Table 5.
Selected publications on disease control rates following postoperative (n > 300) and definitive IMRT (n = 63) in OCC
| Author [ref] | Center | Year | Interval | N | postop IMRT | CT | T3/4 | N>/=2 | lll/lV |
LRC |
D M F S |
O A S |
|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Postop | Definitive | Postop | Definitive | Postop | Definitive | ||||||||||
| Eisbruch et al [3] |
U of MI |
2004 |
1997-2002 |
27 |
most postop |
na |
na |
na |
na |
59% (3y) |
na |
na |
na |
na |
na |
| Yao et al [4] |
U of Iowa |
2007 |
2001-05 |
55 |
49 (89%) |
11% |
56% |
36% |
91% |
85% (3y) |
na |
89% (3y) |
na |
68% (3y) |
na |
| Studer et al [5]∗ |
U of Zurich |
2007 |
2002-07 |
58 |
28 (48%) |
78% |
69% |
28% |
62% |
91% (2y) |
43% (2y) |
95% (2y) |
85% (2y) |
83% (2y) |
30% (2y), n = 30 |
| Gomez et al [12] |
MSKCC |
2009 |
2000-06 |
35 |
35 (100%) |
29% |
40% |
38% |
80% |
77% (3y) |
none |
85% (3y) |
na |
74% (3y) |
none |
| Chen WC et al [13] |
Chiayi, Taiwan |
2009 |
2002-05 |
22 |
22 (100%) |
na |
na |
7 (32%) |
100% |
64% (3y) |
none |
na |
na |
67% (3y) |
none |
| Collan et al [14] |
U of Helsinki |
2011 |
2001-2007 |
40 |
40 (100%) |
38% |
na |
na |
na |
na |
none |
na |
na |
75% (3y) |
none |
| Sher D et al [15] |
DFCI |
2011 |
2004-09 |
42 |
30 (71%) |
~76% |
45% |
30% |
64% |
91% (2y) |
64% (2y) |
94% (2y) |
83% (2y) |
85% (2y) |
63% (2y), n = 12 |
| Daly M et al [16] |
Stanford UMC |
2011 |
2002-09 |
37 |
30 (81%) |
68% |
54% |
46% |
57% |
53% (3y) |
60% (3y) |
81% (3y) |
71% (3y) |
60% (3y) |
57% (3y), n = 7 |
| own cohort | U of Zurich | 2012 | 2002-2011 | 160 | 99 (62%) ∗∗ | 72% | 40% | 77% | 68% | 84% (4y) | 40% (4y) | 90% (4y) | 85% (4y) | 81% (4y) | 38% (4y), n = 44 |
(∗): included in the recent analysis.
(∗∗): included all patients with R0-1 status (excluded 17 operated patients with macroscopic disease after surgery.
U: University Hospital.
MSKCC: Memorial Sloan-Kettering Cancer Center.
DFCI: Dana-Farber Cancer institute.
UMC: University Medical Center.
CT: Chemotherapy.
LRC: loco-regional control.
DMFS: distant metastasis free survival.
OAS: overall survival.